A wide geographical presence, a multinational customer base or a diverse supply chain, organisations are now more globalised than ever before. While this has brought about a wealth of opportunities, it has also created many challenges; the greatest managing the fallout when cultures collide.
Despite the rise of the so-called 'health and safety culture' and increasing regulation across many parts of the world, accidents still happen in the workplace. In 'Changing behaviour in safety critical environments' we explained that in the UK, the Health and Safety Executive estimates that between 2013 and 2014 there was an average of 0.44 deaths per 100,000 workers.
Primeast were sponsors of this year's ATD Houston conference, which focused on 'Talent development in dynamic times'. While organisational agility, sustaining learning and development, and training and development industry trends were the three main themes at the event, one other thing emerged as a key topic: Culture.
In the face of the patent cliff, healthcare reforms across key markets and what some are calling an 'innovation crisis', the pharma industry is being forced to make high impact strategic decisions. Among them is the choice of whether or not to specialise or diversify and in the current climate, there are those passionately advocating the latter as a means to reduce risk.